Davidsson S, Fiorentino M, Andren O, Fang F, Mucci LA, Varenhorst E, et al
A: Tirzepatide is a dual-action medication that targets both GLP-1 and GIP receptors, helping to regulate appetite and enhance insulin sensitivity
The Harris lab is supported by the UW Department of Surgery, School of Medicine and Public Health, Wisconsin Alumni Research Fund, and the Office of the Vice Chancellor for Research
Indeed, the ACVIM's 2009 Consensus Statement specifically recommends, for Stage B dogs, to obtain baseline x-rays
The altered skin sensation has not been reported in the PIONEER-PLUS study or with injectable semaglutide 2.4 mg and its aetiology will need to be explored further in future studies
What specific outcomes are you measuring